266 related articles for article (PubMed ID: 37151376)
1. Exploring the inhibitory potential of novel piperidine-derivatives against main protease (M
Rafique A; Muhammad S; Iqbal J; Al-Sehemi AG; Alshahrani MY; Ayub K; Gilani MA
J Mol Liq; 2023 Jul; 382():121904. PubMed ID: 37151376
[TBL] [Abstract][Full Text] [Related]
2. Virtual Screening of
Miandad K; Ullah A; Bashir K; Khan S; Abideen SA; Shaker B; Alharbi M; Alshammari A; Ali M; Haleem A; Ahmad S
Molecules; 2022 Nov; 27(22):. PubMed ID: 36432204
[TBL] [Abstract][Full Text] [Related]
3. An In silico Investigation to Identify Promising Inhibitors for SARS-CoV-2 M
Alagarsamy V; Sundar PS; Narendhar B; Sulthana MT; Kulkarni VS; Aishwarya AD; Solomon VR; Murugesan S; Jubie S; Rohitha K; Dhanwar S
Med Chem; 2023; 19(9):925-938. PubMed ID: 37069723
[TBL] [Abstract][Full Text] [Related]
4. Development of Effective Therapeutic Molecule from Natural Sources against Coronavirus Protease.
Fadaka AO; Sibuyi NRS; Martin DR; Klein A; Madiehe A; Meyer M
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502340
[TBL] [Abstract][Full Text] [Related]
5. Chromone-embedded peptidomimetics and furopyrimidines as highly potent SARS-CoV-2 infection inhibitors: docking and MD simulation study.
Shakibay Senobari Z; Masoumian Hosseini M; Teimouri MB; Rezayan AH; Samarghandian S; Hekmat A
BMC Res Notes; 2023 Sep; 16(1):224. PubMed ID: 37735703
[TBL] [Abstract][Full Text] [Related]
6. Exploring the potential of novel phenolic compounds as potential therapeutic candidates against SARS-CoV-2, using quantum chemistry, molecular docking and dynamic studies.
Zia M; Muhammad S; Shafiq-urRehman ; Bibi S; Abbasi SW; Al-Sehemi AG; Chaudhary AR; Bai FQ
Bioorg Med Chem Lett; 2021 Jul; 43():128079. PubMed ID: 33940136
[TBL] [Abstract][Full Text] [Related]
7.
Maurya AK; Mishra N
J Biomol Struct Dyn; 2021 Nov; 39(18):7306-7321. PubMed ID: 32835632
[TBL] [Abstract][Full Text] [Related]
8. Targeting COVID-19 (SARS-CoV-2) main protease through active phytochemicals of ayurvedic medicinal plants -
Shree P; Mishra P; Selvaraj C; Singh SK; Chaube R; Garg N; Tripathi YB
J Biomol Struct Dyn; 2022 Jan; 40(1):190-203. PubMed ID: 32851919
[TBL] [Abstract][Full Text] [Related]
9. Investigation of the New Inhibitors by Sulfadiazine and Modified Derivatives of α-D-glucopyranoside for White Spot Syndrome Virus Disease of Shrimp by In Silico: Quantum Calculations, Molecular Docking, ADMET and Molecular Dynamics Study.
Kumer A; Chakma U; Rana MM; Chandro A; Akash S; Elseehy MM; Albogami S; El-Shehawi AM
Molecules; 2022 Jun; 27(12):. PubMed ID: 35744817
[TBL] [Abstract][Full Text] [Related]
10. Computational Evidences of Phytochemical Mediated Disruption of PLpro Driven Replication of SARS-CoV-2: A Therapeutic Approach against COVID-19.
Balkrishna A; Mittal R; Arya V
Curr Pharm Biotechnol; 2021; 22(10):1350-1359. PubMed ID: 33176643
[TBL] [Abstract][Full Text] [Related]
11. A threefold approach including quantum chemical, molecular docking and molecular dynamic studies to explore the natural compounds from Centaurea jacea as the potential inhibitors for COVID-19.
Muhammad S; Maqbool MF; Al-Sehemi AG; Iqbal A; Khan M; Ullah S; Khan MT
Braz J Biol; 2021; 83():e247604. PubMed ID: 34495156
[TBL] [Abstract][Full Text] [Related]
12. Possibility of HIV-1 protease inhibitors-clinical trial drugs as repurposed drugs for SARS-CoV-2 main protease: a molecular docking, molecular dynamics and binding free energy simulation study.
Ancy I; Sivanandam M; Kumaradhas P
J Biomol Struct Dyn; 2021 Sep; 39(15):5368-5375. PubMed ID: 32627689
[TBL] [Abstract][Full Text] [Related]
13. Identification of medicinal plant-based phytochemicals as a potential inhibitor for SARS-CoV-2 main protease (M
Hossain A; Rahman ME; Rahman MS; Nasirujjaman K; Matin MN; Faruqe MO; Rabbee MF
Comput Biol Med; 2023 May; 157():106785. PubMed ID: 36931201
[TBL] [Abstract][Full Text] [Related]
14. Phytochemicals from
Dutta M; Tareq AM; Rakib A; Mahmud S; Sami SA; Mallick J; Islam MN; Majumder M; Uddin MZ; Alsubaie A; Almalki ASA; Khandaker MU; Bradley DA; Rana MS; Emran TB
Biology (Basel); 2021 Aug; 10(8):. PubMed ID: 34440024
[TBL] [Abstract][Full Text] [Related]
15. Some Flavolignans as Potent Sars-Cov-2 Inhibitors
Cetin A
Curr Comput Aided Drug Des; 2022; 18(5):337-346. PubMed ID: 35975852
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory potential of repurposed drugs against the SARS-CoV-2 main protease: a computational-aided approach.
Fadaka AO; Aruleba RT; Sibuyi NRS; Klein A; Madiehe AM; Meyer M
J Biomol Struct Dyn; 2022 May; 40(8):3416-3427. PubMed ID: 33200673
[TBL] [Abstract][Full Text] [Related]
17. Screening of potential inhibitors targeting the main protease structure of SARS-CoV-2
Yang X; Xing X; Liu Y; Zheng Y
Front Pharmacol; 2022; 13():962863. PubMed ID: 36278156
[TBL] [Abstract][Full Text] [Related]
18. In silico and in vitro prediction of new synthesized N-heterocyclic compounds as anti-SARS-CoV-2.
Hashem HE; Ahmad S; Kumer A; Bakri YE
Sci Rep; 2024 Jan; 14(1):1152. PubMed ID: 38212472
[TBL] [Abstract][Full Text] [Related]
19. In Silico Screening of Some Active Phytochemicals to Identify Promising Inhibitors Against SARS-CoV-2 Targets.
Alagarsamy V; Solomon VR; Murugesan S; Sundar PS; Muzaffar-Ur-Rehman MD; Chandu A; Aishwarya AD; Narendhar B; Sulthana MT; Ravikumar V
Curr Drug Discov Technol; 2023 Oct; ():. PubMed ID: 37861016
[TBL] [Abstract][Full Text] [Related]
20. Molecular insights to the binding interactions of APNS containing HIV-protease inhibitors against SARS-CoV-2 M
Purohit P; Dash JJ; Muya JT; Meher BR
J Biomol Struct Dyn; 2023 Jun; 41(9):3900-3913. PubMed ID: 35388744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
